Newly announced data from Eli Lilly’s Phase III BLAZE-1 clinical trial show a combination of two of the company’s monoclonal antibodies, bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016),...
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain Credit: Stan Lim, UC Riverside. RIVERSIDE, Calif. — Variants of the...
Making A List Of Penny Stocks? 4 High Volume Names Turning Heads This Week
COVID Outbreak Confirmed At Nursing Home Despite Staff, Patients Being Vaccinated As new COVID cases tumble across North America, sleepy British Columbia has just reported a...
With four COVID-19 vaccines approved for use in Canada, it's time to answer FAQs about efficacy, immunity, eradication and variants.
The coronavirus pandemic has driven a lot of scientific progress in the past year. But just as some of the social changes are likely here to...
Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study
Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – The post ExeVir ready for clinic with variant-targeting...
Researchers are closely watching the coronavirus mutants to make sure vaccines can be adjusted if necessary. But scientists don't know whether vaccines will be effective in...
The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 with severe risk.
Eli Lilly and Co. received praise from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its antibody treatment for confirmed...
Credit: Vanderbilt University Medical Center A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known...
A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause...
Nine great apes at the San Diego Zoo – four orangutans and five bonobos – made veterinary history in recent weeks as the world’s first non-human...
Immunity fades rapidly for some infections (influenza) but lasts a lifetime with others (measles). Here's what we know about COVID.
With multiple variants of concern now present in most countries the attention is turning to when updated vaccines for them will be ready.
Worrisome new coronavirus variants can evade antibodies that neutralize original virus Credit: Matt Miller/Washington University New research at Washington University School of Medicine in St. Louis...
CureVac NV inked a deal with Switzerland’s Novartis AG to manufacture the German biopharmaceutical company’s Covid-19 vaccine candidate, CVnCoV.
Credit: © Laura Alvarez / CeMM The body’s immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the...
Another study is adding to a growing body of literature that suggests convalescent plasma from recovered patients with Covid-19 does not prevent further Covid-19 progression in...
Preclinical study outcomes are more likely to predict clinical study outcomes if new, bet-ter-humanized small animal models are deployed. The post Animal Models Offer Improved Translatability...
New immunotherapy developments include the use of tumor-infiltrating lymphocytes, allogeneic T cells, co-stimulatory signals, and engineered cytokines. The post Reinforcing the Body’s Defenses against Cancer appeared...
In this roundtable discussion, four experts from academia and industry met to discuss challenges in refining and scaling up AAV production pipelines to meet the increasing...
Perhaps we should rethink how we monitor pregnant women who have COVID.
Vir Biotechnology and GlaxoSmithKline said they will pause enrollment into a study testing their experimental Covid-19 antibody therapy
The US was not ready for the coronavirus pandemic in 2020. What can public health leaders and policymakers do to make sure we don't face another...
Are These Hot Penny Stocks On Your List To Watch This Week? 5 Active Names To Watch This Week
Another trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to The post NIH abandons convalescent plasma trial in...
New Cleveland Clinic-led research published in mBio Credit: Cleveland Clinic CLEVELAND – Researchers from Cleveland Clinic’s Global Center for Pathogen Research & Human Health have developed...
Novavax Chief Executive Officer Stanley Erck believes the U.S. Food and Drug Administration could grant Emergency Use Authorization (EUA) for the company's Covid-19 vaccine by May.